PACTR201906665550709

IDA for Onchocerciasis

Safety and efficacy of combination therapy with ivermectin, diethylcarbamazine, and albendazole (IDA) for individuals with onchocerciasis
Washington University in St. Louis; Case Western Reserve University ; University of Health and Allied Sciences·Not Applicable·Pan Africa Clinical Trials RegistryNot yet recruiting
Study focus
Sponsor & location
Primary sponsor
Washington University in St. Louis; Case Western Reserve University ; University of Health and Allied Sciences
Funder
Bill and Melinda Gates Foundation
Location
Pan Africa
Timeline & enrollment
Phase
Not Applicable
Start date
Jan 01, 1900
End date
Jan 01, 1900
Summary

This study will provide preliminary data on the safety of IDA treatment in persons with onchocerciasis when it is administered after pre-treatment with IVM to clear or greatly reduce microfilariae from the skin and eyes. Widespread use of IDA following IVM pretreatment (I/IDA) has the potential to greatly accelerate elimination of LF in African countries that are coendemic for LF and onchocerciasis. This study will also assess the efficacy of IDA for killing and sterilizing adult filarial worms. An improved macrofilaricidal treatment would be a major advance for the global program to eliminate onchocerciasis. Since the safety and efficacy objectives are both very important, we have included dual primary objectives for the study.

ICD-10 classifications
Certain infectious and parasitic diseasesOther infestationsInfestation, unspecifiedOther specified infestationsOther infectious diseases
Data source
Registry
Pan Africa Clinical Trials Registry
Trial ID
PACTR201906665550709
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for PACTR201906665550709 through Pure Global AI's free database. This Not Applicable trial is sponsored by Washington University in St. Louis; Case Western Reserve University ; University of Health and Allied Sciences and is currently Not yet recruiting. The study focuses on Infections and Infestations.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.